Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $640.91 million. The enterprise value is $280.89 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 98.45 million shares outstanding. The number of shares has increased by 105.53% in one year.
| Current Share Class | 98.45M |
| Shares Outstanding | 98.45M |
| Shares Change (YoY) | +105.53% |
| Shares Change (QoQ) | +15.92% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 56.62% |
| Float | 53.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.10, with a Debt / Equity ratio of 0.06.
| Current Ratio | 13.10 |
| Quick Ratio | 12.57 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.37% and return on invested capital (ROIC) is -34.45%.
| Return on Equity (ROE) | -57.37% |
| Return on Assets (ROA) | -32.03% |
| Return on Invested Capital (ROIC) | -34.45% |
| Return on Capital Employed (ROCE) | -50.04% |
| Weighted Average Cost of Capital (WACC) | 17.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.58M |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +135.02% in the last 52 weeks. The beta is 2.47, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.47 |
| 52-Week Price Change | +135.02% |
| 50-Day Moving Average | 7.57 |
| 200-Day Moving Average | 6.18 |
| Relative Strength Index (RSI) | 37.90 |
| Average Volume (20 Days) | 1,109,166 |
Short Selling Information
The latest short interest is 8.81 million, so 8.95% of the outstanding shares have been sold short.
| Short Interest | 8.81M |
| Short Previous Month | 9.44M |
| Short % of Shares Out | 8.95% |
| Short % of Float | 16.39% |
| Short Ratio (days to cover) | 9.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -196.46M |
| Pretax Income | -191.78M |
| Net Income | -191.78M |
| EBITDA | -194.84M |
| EBIT | -196.46M |
| Earnings Per Share (EPS) | -$1.95 |
Full Income StatementBalance Sheet
The company has $380.68 million in cash and $20.67 million in debt, with a net cash position of $360.01 million or $3.66 per share.
| Cash & Cash Equivalents | 380.68M |
| Total Debt | 20.67M |
| Net Cash | 360.01M |
| Net Cash Per Share | $3.66 |
| Equity (Book Value) | 374.13M |
| Book Value Per Share | 3.80 |
| Working Capital | 366.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$171.67 million and capital expenditures -$1.19 million, giving a free cash flow of -$172.86 million.
| Operating Cash Flow | -171.67M |
| Capital Expenditures | -1.19M |
| Depreciation & Amortization | 1.62M |
| Net Borrowing | -588,000 |
| Free Cash Flow | -172.86M |
| FCF Per Share | -$1.76 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -105.53% |
| Shareholder Yield | -105.53% |
| Earnings Yield | -29.92% |
| FCF Yield | -26.97% |
Analyst Forecast
The average price target for SLDB is $17.00, which is 161.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 161.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
